|Day Low/High||32.80 / 33.95|
|52 Wk Low/High||17.92 / 73.23|
In trading on Friday, shares of AMAG Pharmaceuticals, Inc. crossed below their 200 day moving average of $24.16, changing hands as low as $23.74 per share.
Investors considering a purchase of AMAG Pharmaceuticals, Inc. stock, but tentative about paying the going market price of $24.29/share, might benefit from considering selling puts among the alternative strategies at their disposal.
In trading on Thursday, shares of AMAG Pharmaceuticals, Inc. crossed above their 200 day moving average of $24.42, changing hands as high as $24.60 per share.
Trade-Ideas LLC identified AMAG Pharmaceuticals (AMAG) as a "perilous reversal" (up big yesterday but down big today) candidate
Investors in AMAG Pharmaceuticals, Inc. saw new options begin trading this week, for the February 2017 expiration.
The daily chart flashes hope as bulls push out of a bullish flag.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Now that the Allergan-Pfizer merger is off, Allergan CEO Saunders could start shopping again for biotech and smaller pharma companies to fuel his company's growth.
Company also Announces Expansion of Home Healthcare Support through Makena Care Connection
Trade-Ideas LLC identified AMAG Pharmaceuticals (AMAG) as a strong on high relative volume candidate
The most recent short interest data has been released by the NASDAQ for the 03/15/2016 settlement date, which shows a 1,095,548 share increase in total short interest for AMAG Pharmaceuticals, Inc. , to 8,886,140, an increase of 14.06% since 02/29/2016.
Trade-Ideas LLC identified AMAG Pharmaceuticals (AMAG) as a "dead cat bounce" (down big yesterday but up big today) candidate